Marissa J Maroni, Melissa Barton, Katherine Lynch, Ashish R Deshwar, Philip D Campbell, Josephine Millard, Rachel Lee, Annastelle Cohen, Rili Ahmad, Alekh Paranjapye, Víctor Faundes, Gabriela M Repetto, Caoimhe McKenna, Amelle L Shillington, Chanika Phornphutkul, Hanne B Hove, Grazia M S Mancini, Rachel Schot, Tahsin Stefan Barakat, Christopher M Richmond, Julie Lauzon, Ahmed Ibrahim Elsayed Ibrahim, Caroline Nava, Delphine Héron, Minke M A van Aalst, Slavena Atemin, Mila Sleptsova, Iliyana Aleksandrova, Albena Todorova, Debra L Watkins, Mariya A Kozenko, Daniel Natera-de Benito, Carlos Ortez, Berta Estevez-Arias, François Lecoquierre, Kévin Cassinari, Anne-Marie Guerrot, Jonathan Levy, Xenia Latypova, Alain Verloes, A Micheil Innes, Xiao-Ru Yang, Siddharth Banka, Katharina Vill, Maureen Jacob, Michael Kruer, Peter Skidmore, Carolina I Galaz-Montoya, Somayeh Bakhtiari, Jessica L Mester, Michael Granato, Karim-Jean Armache, Gregory Costain, Erica Korb
{"title":"Loss of DOT1L disrupts neuronal transcription and leads to a neurodevelopmental disorder","authors":"Marissa J Maroni, Melissa Barton, Katherine Lynch, Ashish R Deshwar, Philip D Campbell, Josephine Millard, Rachel Lee, Annastelle Cohen, Rili Ahmad, Alekh Paranjapye, Víctor Faundes, Gabriela M Repetto, Caoimhe McKenna, Amelle L Shillington, Chanika Phornphutkul, Hanne B Hove, Grazia M S Mancini, Rachel Schot, Tahsin Stefan Barakat, Christopher M Richmond, Julie Lauzon, Ahmed Ibrahim Elsayed Ibrahim, Caroline Nava, Delphine Héron, Minke M A van Aalst, Slavena Atemin, Mila Sleptsova, Iliyana Aleksandrova, Albena Todorova, Debra L Watkins, Mariya A Kozenko, Daniel Natera-de Benito, Carlos Ortez, Berta Estevez-Arias, François Lecoquierre, Kévin Cassinari, Anne-Marie Guerrot, Jonathan Levy, Xenia Latypova, Alain Verloes, A Micheil Innes, Xiao-Ru Yang, Siddharth Banka, Katharina Vill, Maureen Jacob, Michael Kruer, Peter Skidmore, Carolina I Galaz-Montoya, Somayeh Bakhtiari, Jessica L Mester, Michael Granato, Karim-Jean Armache, Gregory Costain, Erica Korb","doi":"10.1093/brain/awaf212","DOIUrl":null,"url":null,"abstract":"Individuals with monoallelic gain-of-function variants in the histone lysine methyltransferase DOT1L display global developmental delay and varying congenital anomalies. However, the impact of monoallelic loss of DOT1L remains unclear. Here, we sought to define the effects of partial DOT1L loss by applying bulk and single-nucleus RNA-sequencing, ChIP-sequencing, imaging, multielectrode array recordings, and behavioral analysis of zebrafish and multiple mouse models. We present a cohort of 16 individuals (12 females, 4 males) with neurodevelopmental disorders and monoallelic DOT1L variants, including a frameshift deletion, an in-frame deletion, a nonsense, and missense variants clustered in the catalytic domain. We demonstrate that specific variants cause loss of methyltransferase activity. In primary cortical neurons, Dot1l knockdown disrupts transcription of synaptic genes, neuron branching, expression of a synaptic protein, and neuronal activity. Further in the cortex of heterozygous Dot1l mice, Dot1l loss causes sex-specific transcriptional responses and H3K79me2 depletion, including within down-regulated genes. Lastly using both zebrafish and mouse models, we found behavioral disruptions that include developmental deficits and sex-specific social behavioral changes. Overall, we define how DOT1L loss leads to neurological dysfunction by demonstrating that partial Dot1l loss impacts neuronal transcription, neuron morphology, and behavior across multiple models and systems.","PeriodicalId":9063,"journal":{"name":"Brain","volume":"10 1","pages":""},"PeriodicalIF":10.6000,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/brain/awaf212","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Individuals with monoallelic gain-of-function variants in the histone lysine methyltransferase DOT1L display global developmental delay and varying congenital anomalies. However, the impact of monoallelic loss of DOT1L remains unclear. Here, we sought to define the effects of partial DOT1L loss by applying bulk and single-nucleus RNA-sequencing, ChIP-sequencing, imaging, multielectrode array recordings, and behavioral analysis of zebrafish and multiple mouse models. We present a cohort of 16 individuals (12 females, 4 males) with neurodevelopmental disorders and monoallelic DOT1L variants, including a frameshift deletion, an in-frame deletion, a nonsense, and missense variants clustered in the catalytic domain. We demonstrate that specific variants cause loss of methyltransferase activity. In primary cortical neurons, Dot1l knockdown disrupts transcription of synaptic genes, neuron branching, expression of a synaptic protein, and neuronal activity. Further in the cortex of heterozygous Dot1l mice, Dot1l loss causes sex-specific transcriptional responses and H3K79me2 depletion, including within down-regulated genes. Lastly using both zebrafish and mouse models, we found behavioral disruptions that include developmental deficits and sex-specific social behavioral changes. Overall, we define how DOT1L loss leads to neurological dysfunction by demonstrating that partial Dot1l loss impacts neuronal transcription, neuron morphology, and behavior across multiple models and systems.
期刊介绍:
Brain, a journal focused on clinical neurology and translational neuroscience, has been publishing landmark papers since 1878. The journal aims to expand its scope by including studies that shed light on disease mechanisms and conducting innovative clinical trials for brain disorders. With a wide range of topics covered, the Editorial Board represents the international readership and diverse coverage of the journal. Accepted articles are promptly posted online, typically within a few weeks of acceptance. As of 2022, Brain holds an impressive impact factor of 14.5, according to the Journal Citation Reports.